Stocks
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1.11 | -39.0 | -82.6 | -200.9 | 39.9 | -212.0 | ||
| Changes by years, y/y, % | -3 601% | +112% | +143% | -120% | +144.6% | ||||
Amylyx Pharmaceuticals. EBITDA US GAAP, bln rub
Amylyx Pharmaceuticals. EBITDA US GAAP, changes, %
Amylyx Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 19.0 | 2.24 | -121.8 | -53.2 | -39.2 | -212.0 | |
| Changes by years, y/y, % | -135% | -105% | +5 834% | -360% | -306% | |||
| Changes by quarters, q/q, % | -7% | -88% | -5 550% | -56% | -26% | |||
